William D Young's Net Worth

$16.3 Million

Estimate Recalculated Nov 1, 2024 04:29AM EST

Who is William D Young?

William D Young has an estimated net worth of $16.3 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, THERAVANCE INC, BIOMARIN PHARMACEUTICAL INC, Praxis Precision Medicines, Inc., Theravance Biopharma, Inc., HUMAN GENOME SCIENCES INC, VAXGEN INC, and VIROLOGIC INC.

SEC CIK

William D Young's CIK is 0001217420

Past Insider Trading and Trends

2008 was William D Young's most active year for acquiring shares with 13 total transactions. William D Young's most active month to acquire stocks was the month of April. 2019 was William D Young's most active year for disposing of shares, totalling 5 transactions. William D Young's most active month to dispose stocks was the month of November. 2019 saw William D Young paying a total of $1,969,500.00 for 46,766 shares, this is the most they've acquired in one year. In 2019 William D Young cashed out on 60,000 shares for a total of $6,562,715.24, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
$145.54
-$2,935,895.76
9.31K
Scheduled
Jan 2
Form 4
—
0
$142.20
-$4,593,215.24
9.31K
Scheduled
Dec 30
Form 4
+34.36%
2.38K
—
—
9.31K
Jun 1
Form 4
+35.11%
1.8K
—
—
6.93K
Jun 1
Form 4
+74.40%
2.19K
—
—
5.13K
Jun 1
Form 4
∞
2.94K
$0.01
$29.41
2.94K
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 7
Form 3
—
0
—
—
0
No matching records found

THERAVANCE INC (INVA) Snapshot price: $18.7201

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.70%
6K
—
—
83.94K
May 22
Form 4
+49.50%
25.81K
$9.69
$249,995.63
77.94K
Apr 7
Form 4
+13.01%
6K
—
—
52.13K
Apr 24
Form 4
+14.95%
6K
—
—
46.13K
May 15
Form 4
+17.58%
6K
—
—
40.13K
Apr 27
Form 4
+18.70%
5.38K
$15.42
-$28,277.76
34.13K
Mar 7
Form 4
+23.00%
5.38K
$15.88
-$33,169.92
28.75K
Feb 18
Form 4
+29.87%
5.38K
$17.59
-$51,565.43
23.38K
Dec 10
Form 4
+50.00%
6K
—
—
18K
Apr 27
Form 4
+100.00%
6K
—
—
12K
Apr 24
Form 4
∞
6K
—
—
6K
Apr 22
Form 4
—
0
—
—
0
Apr 25
Form 4
—
0
—
—
0
Apr 26
Form 4
—
0
—
—
0
Jun 30
Form 3
—
0
—
—
0
No matching records found

BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+10.21%
1.1K
—
—
11.88K
Jun 10
Form 4
+24.21%
2.1K
—
—
10.78K
Jun 4
Form 4
+64.45%
3.4K
—
—
8.68K
May 15
Form 4
+181.33%
3.4K
—
—
5.28K
May 8
Form 4
∞
1.88K
—
—
1.88K
May 12
Form 4
—
0
—
—
0
Sep 22
Form 3
—
0
—
—
0
No matching records found

Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $54.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
May 26
Form 4
∞
28.47K
—
—
28.47K
May 13
Form 4
—
0
—
—
0
Jun 8
Form 3
—
0
—
—
0
No matching records found

Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+14.45%
9.85K
—
—
78.01K
Apr 26
Form 4
+16.85%
9.83K
—
—
68.16K
Apr 27
Form 4
+12.83%
6.63K
—
—
58.33K
Apr 28
Form 4
+19.36%
8.38K
—
—
51.7K
Apr 30
Form 4
+23.31%
8.19K
—
—
43.31K
May 1
Form 4
+20.60%
6K
—
—
35.12K
May 17
Form 4
+25.95%
6K
—
—
29.12K
May 3
Form 4
+35.04%
6K
—
—
23.12K
Apr 22
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found